- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IB Lung Non-Small Cell Carcinoma AJCC v7 in Germany
Total 595 results
-
BayerCompletedNon Small Cell Lung CancerFrance, Germany
-
Astellas Pharma IncCompletedLung Cancer | Carcinoma, Non-Small Cell Lung | Cancer of Lung | Non-Small Cell Lung Carcinoma | Cancer of the LungGermany, Czech Republic, Netherlands
-
Thoraxklinik-Heidelberg gGmbHCompletedNon Small Cell Lung CancerBelgium, Germany, Luxembourg
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
Pierre Fabre Pharma GmbHiOMEDICO AGCompletedMetastatic Breast Cancer | Non Small Cell Lung CarcinomaGermany
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerAustralia, Germany, United States
-
CureVacCompletedNon Small Cell Lung CancerSwitzerland, Germany
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerGermany
-
Regeneron PharmaceuticalsSanofiTerminatedAdvanced Non-Small Cell Lung CarcinomaUnited States, Belgium, France, Germany, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
AstraZenecaTerminatedSquamous Non Small Cell Lung CancerSpain, United States, Germany
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHCompleted
-
Technische Universität DresdenGerman Cancer Research Center; National Center for Radiation Research in Oncology...RecruitingNon-Small Cell Lung CancerGermany
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
iOMEDICO AGRoche Pharma AGCompletedExtensive-stage Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBCGermany
-
Goethe UniversityRecruitingNSCLC Stage IV | NSCLC Stage IIIBGermany
-
OncoHost Ltd.RecruitingStage IV Non-small Cell Lung Cancer | Stage III Malignant Melanoma | Stage IV Small Cell Lung Cancer | Stage IV Malignant MelanomaUnited States, Israel, United Kingdom, Germany, Spain
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerSpain, Italy, Germany, France
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerGermany, Taiwan, Australia, China, Korea, Republic of
-
Institut für Klinische Krebsforschung IKF GmbH...Thoraxklinik-Heidelberg gGmbHActive, not recruitingThoracic Radiotherapy | Small Cell Lung Cancer Extensive StageGermany, Austria
-
Novartis PharmaceuticalsCompletedLocally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 MutationsGermany
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
TransgeneTerminatedNon-Small-Cell Lung CarcinomaUnited States, France, Hungary, United Kingdom, Spain, Israel, Belgium, Germany, Poland, Italy
-
CureVacTerminatedNon-Small Cell Lung CarcinomaGermany, Switzerland, Austria
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
LMU KlinikumDepartment of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich... and other collaboratorsRecruitingOncology | NSCLC, Stage III | Chemoradiotherapy | Biomarker | DurvalumabGermany
-
University Hospital, EssenRecruiting
-
Johannes Gutenberg University MainzTerminated
-
University of CologneCompletedNon-Small Cell Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificGermany
-
ETOP IBCSG Partners FoundationAmgen; Eisai Inc.WithdrawnMetastatic Non Small Cell Lung Cancer | KRAS G12CSpain, Switzerland, Austria, Germany
-
Eisai Inc.Quintiles, Inc.CompletedNon Small Cell Lung CancerUkraine, Germany, United States, Italy, Czechia
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
Universität des SaarlandesRecruitingExtensive-stage Small-cell Lung CancerGermany
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerFrance, Spain, United States, Belgium, Netherlands, Canada, Italy, Singapore, Korea, Republic of, Czechia, Germany, Hong Kong
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellGermany, United Kingdom
-
BayerAmgenCompletedCancer | Carcinoma, Non-Small Cell LungUnited States, Germany
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingCarcinoma, Non-small-Cell LungKorea, Republic of, United States, Spain, Germany
-
Eli Lilly and CompanyCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway